TRACON Pharmaceuticals Inc Shares Close the Week 26.1% Lower - Weekly Wrap
The company saw its shares close the week 26.1% lower than last week, with trading volume higher than its 30 day average.
Jul 25, 2021 by Kwhen Finance Editors
TRACON Pharmaceuticals Inc (TCON) shares closed this week 26.1% lower than it did at the end of last week. The stock is currently down 67.5% year-to-date, up 107.7% over the past 12 months, and down 92.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 2.0%.
Trading Activity
- Shares traded as high as $5.43 and as low as $3.51 this week.
- Shares closed 68.9% below its 52-week high and 145.2% above its 52-week low.
- Trading volume this week was 267.8% higher than the 10-day average and 792.6% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
TRACON Pharmaceuticals Inc | 2.2 | -67.5 | 107.7 | -69.7 | 138.7 |
Dow Jones Industrial Average | 0.7 | 15.7 | 34.8 | -0.3 | 37.1 |
S&P 500 Index | 1.0 | 18.4 | 39.1 | -0.6 | 38.9 |
Health Care | 1.1 | 16.2 | 26.6 | -0.8 | 31.3 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -579.0%
- The company's stock price performance over the past 12 months beats the peer average by -1143.2%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
TRACON Pharmaceuticals Inc | TCON | 0 | -67.5 | 107.7 | -69.7 | 138.7 |
Peer Avg | N/A | -1.6 | 14.1 | -10.3 | -36.4 | 39.8 |
Agenus Inc | AGEN | -6.6 | 76.7 | 73.5 | -6.4 | 122.8 |
Akebia Therapeutics Inc. | AKBA | 0 | -11.8 | -79.0 | -79.2 | 24.4 |
Applied Genetic Technologies Corp | AGTC | 0 | -8.6 | -35.7 | -59.9 | 11.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: